Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) — Free Cash Flow Generation Index
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) has a Free Cash Flow Generation Index of 0.76x as of March 2023. Free cash flow of €142.49 Million represents 1% of operating cash flow (€186.97 Million). See working capital position of Tianjin Zhong Xin Pharmaceutical Group C to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Free Cash Flow Generation Index (2013–2025)
Historical FCF Generation Index trend for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited across 12 annual periods. Explore 2TZ operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2013–2025)
Year-by-year Free Cash Flow Generation Index for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited. For the full company profile including market capitalisation, see market cap of Tianjin Zhong Xin Pharmaceutical Group C.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.74x | €342.45 Million | €461.07 Million | €118.61 Million | ▼ -14.9% |
| 2024 | 0.87x | €806.86 Million | €924.67 Million | €117.81 Million | ▲ +9.7% |
| 2023 | 0.80x | €547.56 Million | €688.49 Million | €140.93 Million | ▼ -5.4% |
| 2022 | 0.84x | €569.34 Million | €677.25 Million | €107.90 Million | ▲ +3.0% |
| 2021 | 0.82x | €695.45 Million | €852.40 Million | €156.95 Million | ▲ +13.6% |
| 2020 | 0.72x | €482.26 Million | €671.42 Million | €189.16 Million | ▲ +22.8% |
| 2019 | 0.59x | €289.87 Million | €495.49 Million | €205.61 Million | ▲ +17.5% |
| 2018 | 0.50x | €174.34 Million | €350.14 Million | €175.81 Million | ▼ -61.0% |
| 2016 | 1.28x | €533.98 Million | €417.77 Million | €116.20 Million | ▲ +1.7% |
| 2015 | 1.26x | €453.22 Million | €360.58 Million | €92.64 Million | ▲ +1.0% |
| 2014 | 1.24x | €357.01 Million | €286.85 Million | €70.15 Million | ▼ -7.1% |
| 2013 | 1.34x | €285.86 Million | €213.44 Million | €72.42 Million | — |